Saturday, 26 March 2022

Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV in Older Adults

submitted by /u/shallah
[link] [comments]

from Health https://ift.tt/SN9VFkQ

No comments:

Post a Comment